亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Inhibition Of Sars-Associated Coronavirus (Scov) Infection And Replication By Rna Interference

总结
The Present Invention Relates To Therapeutic Agents Useful For The Treatment Of Severe Acute Respiratory Syndrome (Sars) In Humans. In Particular, The Present Invention Relates To Rna Interference (Rnai) Molecules Useful For Inhibiting The Infection And Replication Of Hsars Virus. Preferably, The Rnai Molecules Target The Replicase Region Of The Hsars Virus, Or Combinations Of Different Sites Of Hsars Virus Genes. The Present Invention Further Encompasses Methods Of Using The Rnai Molecules For Preventing And/Or Treating Sars. Vaccines And Kits Comprising Therapeutically Effective Amounts Of The Rnai Molecules Are Also Encompassed.
申请号码
US2006452267A
国家/地区
香港

欲了解更多信息,请点击 这里
移动设备